Biogen Inc (BIIB)

234.72 +7.89  +3.48% NASDAQ Dec 8, 16:00 236.00 +1.28  +0.55% After-Hours: 05:54 USD

Biogen Cash from Investing (TTM):

-617.40M for Sept. 30, 2021
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Investing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (TTM) Data

View and export this data going back to 1990. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 -617.40M
June 30, 2021 -436.20M
March 31, 2021 -1.116B
Dec. 31, 2020 -608.60M
Sept. 30, 2020 266.20M
June 30, 2020 -47.30M
March 31, 2020 674.60M
Dec. 31, 2019 470.50M
Sept. 30, 2019 -1.863B
June 30, 2019 -2.116B
March 31, 2019 -3.154B
Dec. 31, 2018 -2.046B
Sept. 30, 2018 -1.190B
June 30, 2018 -1.818B
March 31, 2018 -872.30M
Dec. 31, 2017 -2.963B
Sept. 30, 2017 -2.775B
June 30, 2017 -1.492B
March 31, 2017 -2.026B
Dec. 31, 2016 -2.485B
Sept. 30, 2016 -3.711B
June 30, 2016 -4.737B
March 31, 2016 -5.254B
Dec. 31, 2015 -4.554B
Sept. 30, 2015 -3.124B
   
June 30, 2015 -2.675B
March 31, 2015 -2.052B
Dec. 31, 2014 -1.543B
Sept. 30, 2014 -1.875B
June 30, 2014 -1.659B
March 31, 2014 -1.755B
Dec. 31, 2013 -1.605B
Sept. 30, 2013 -1.270B
June 30, 2013 -1.468B
March 31, 2013 -795.02M
Dec. 31, 2012 -950.34M
Sept. 30, 2012 -964.42M
June 30, 2012 -1.029B
March 31, 2012 -1.523B
Dec. 31, 2011 -1.650B
Sept. 30, 2011 -1.779B
June 30, 2011 -1.262B
March 31, 2011 -31.21M
Dec. 31, 2010 345.32M
Sept. 30, 2010 1.247B
June 30, 2010 841.89M
March 31, 2010 -53.59M
Dec. 31, 2009 -395.03M
Sept. 30, 2009 -1.243B
June 30, 2009 -868.45M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Benchmarks

Ionis Pharmaceuticals Inc 287.65M
Sage Therapeutics Inc -926.67M
Moderna Inc -7.575B

Cash from Investing (TTM) Range, Past 5 Years

Minimum -3.154B Mar 2019
Maximum 674.60M Mar 2020
Average -1.311B

News

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.